Darren H Freed1, Anna M Borowiec, Tatjana Angelovska, Ian M C Dixon. 1. Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, Faculty of Medicine, University of Manitoba, 351 Tache Ave, Winnipeg, Manitoba, Canada R2H 2A6.
Abstract
OBJECTIVE: Cardiotrophin-1 (CT-1) is a member of the IL-6 family of cytokines and is expressed in various cardiovascular disease states. CT-1 induces cardiomyocyte hypertrophy, and protects myocytes from ischemia reperfusion injury. We sought to elucidate CT-1 signaling in cardiac fibroblasts with respect to initiation of protein synthesis. METHODS: Cardiac fibroblasts were isolated from the ventricles of 200-g Sprague-Dawley rats and stimulated with CT-1 at specified concentrations with or without inhibitors of cell signaling pathways. Activation of intracellular signaling pathways was determined by Western analysis and immunocytochemistry. Protein synthesis was measured by incorporation of [3H]leucine. RESULTS: CT-1 treatment resulted in activation of the Jak/STAT, MAPK, and Akt pathways in addition to protein synthesis regulatory proteins with resultant increase in overall protein synthesis. Analysis with phospho-specific antibodies revealed that AG490 (Jak inhibitor), PD98059 (MEK1/2 inhibitor), SB203580 (p38 MAPK inhibitor), LY294002 (PI3-K inhibitor) and rapamycin (mTOR inhibitor) act at different levels in the signaling cascade to inhibit CT-1 induced protein synthesis. CONCLUSION: Cardiotrophin-1 activates the Jak/STAT, PI3K/Akt, p38 and p42/44 MAPK pathways in cardiac fibroblasts. Use of pharmacologic inhibitors reveals that each of these pathways play a role in CT-1 induced protein synthesis.
OBJECTIVE:Cardiotrophin-1 (CT-1) is a member of the IL-6 family of cytokines and is expressed in various cardiovascular disease states. CT-1 induces cardiomyocyte hypertrophy, and protects myocytes from ischemia reperfusion injury. We sought to elucidate CT-1 signaling in cardiac fibroblasts with respect to initiation of protein synthesis. METHODS: Cardiac fibroblasts were isolated from the ventricles of 200-g Sprague-Dawley rats and stimulated with CT-1 at specified concentrations with or without inhibitors of cell signaling pathways. Activation of intracellular signaling pathways was determined by Western analysis and immunocytochemistry. Protein synthesis was measured by incorporation of [3H]leucine. RESULTS:CT-1 treatment resulted in activation of the Jak/STAT, MAPK, and Akt pathways in addition to protein synthesis regulatory proteins with resultant increase in overall protein synthesis. Analysis with phospho-specific antibodies revealed that AG490 (Jak inhibitor), PD98059 (MEK1/2 inhibitor), SB203580 (p38 MAPK inhibitor), LY294002 (PI3-K inhibitor) and rapamycin (mTOR inhibitor) act at different levels in the signaling cascade to inhibit CT-1 induced protein synthesis. CONCLUSION:Cardiotrophin-1 activates the Jak/STAT, PI3K/Akt, p38 and p42/44 MAPK pathways in cardiac fibroblasts. Use of pharmacologic inhibitors reveals that each of these pathways play a role in CT-1 induced protein synthesis.
Authors: Michael R Zile; Stacia M Desantis; Catalin F Baicu; Robert E Stroud; Sheila B Thompson; Catherine D McClure; Shannon M Mehurg; Francis G Spinale Journal: Circ Heart Fail Date: 2011-02-24 Impact factor: 8.790
Authors: Dan Liu; Yi Huang; Jing Zeng; Bojiang Chen; Na Huang; Na Guo; Lunxu Liu; Hong Xu; Xianming Mo; Weimin Li Journal: J Cancer Res Clin Oncol Date: 2011-08-23 Impact factor: 4.553
Authors: Han-Kyu Lee; Bumsup Kwon; Cynthia A Lemere; Suzanne de la Monte; Kyohei Itamura; Austin Y Ha; Henry W Querfurth Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Mun-Kit Choy; Mehregan Movassagh; Lee Siggens; Ana Vujic; Martin Goddard; Ana Sánchez; Neil Perkins; Nichola Figg; Martin Bennett; Jason Carroll; Roger Foo Journal: Genome Med Date: 2010-06-14 Impact factor: 11.117
Authors: Xu Wen Ng; Yingying Huang; Horng H Chen; John C Burnett; Freddy Y C Boey; Subbu S Venkatraman Journal: PLoS One Date: 2013-07-04 Impact factor: 3.240